API Corporation is a pioneering development company in the specialty chemicals field, specialising in research and development of cutting-edge bio and organic synthesis technologies. As a prominent player in the pharmaceutical industry, API focuses on providing Active Pharmaceutical Ingredients (APIs) alongside Contract Development and Manufacturing Organisation (CDMO) services. Their extensive expertise in innovative process development and regulatory services positions them as a trusted partner for pharmaceutical companies seeking high-quality chemical solutions.

Services include:
– APIs (Active Pharmaceutical Ingredients)
– Contract Manufacturing (CMO)
– CDMO services
– Regulatory Services

API is committed to advancing the pharmaceutical sector through their comprehensive range of services designed to meet the evolving needs of their clients. For more information, please visit api-corp.co.jp.